Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Dómine, Philip R. Clingan, Maximilian J. Hochmair, Steven Powell, Susanna Y. Cheng, Helge Bischoff, Nir Peled, Francesco Grossi, Ross Jennens, Martin Reck, Rina Hui, Edward B. Garon, Michael Boyer, Belén Rubio‐Viqueira, Silvia Novello, Takayasu Kurata, Jhanelle E. Gray, John Vida, Ziwen Wei, Jing Yang, Harry Raftopoulos, M. Catherine Pietanza, Marina Chiara Garassino

New England Journal of Medicine, 2018

NYU Langone’s Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, Hospital Universitario Insular de Gran Canaria, Universidad de Las Palmas de Gran Canaria, The Barbara Ann Karmanos Cancer Institute, Hospital Universitario Central de Asturias, Vall d'Hebron Institute of Oncology, Hebron University, Hospital Universitario Fundación Jiménez Díaz, Otto Wagner Hospital, Sanford Health, Sunnybrook Health Science Centre, Health Sciences Centre, Rabin Medical Center, Tel Aviv University, Ospedale Policlinico San Martino, Epworth Hospital, German Center for Lung Research, The University of Sydney, Westmead Hospital, University of California, Los Angeles, Chris O’Brien Lifehouse, Hospital Universitario Quirónsalud Madrid, Ospedale San Luigi Gonzaga, University of Turin, Kansai Medical University, Moffitt Cancer Center, Merck & Co., Inc., Rahway, NJ, USA (United States), Fondazione IRCCS Istituto Nazionale dei Tumori

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

6500

Citations

View on Google Scholar

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Abstract

Journal Details

Join JournalsHub

Welcome Back